Cerebrolysin in relatives of people with Alzheimer’s disease: 30-month comparison
Comparison in people · 2023
- What was studied
- 88 first-degree relatives with amnestic mild cognitive impairment, aged 50–82. Forty-six received Cerebrolysin and 42 were untreated.
- Main finding
- The 88-person study reported dementia conversions only in the untreated comparison. The authors gave a 9.5% annual conversion figure for that group.
Reported findings and study design
Prospective comparison of repeated annual infusion courses with untreated follow-up. Assessment used neuropsychological tests and CGI-I.
Population or model 88 first-degree relatives with amnestic mild cognitive impairment, aged 50–82. Forty-six received Cerebrolysin and 42 were untreated.
Dose, route and schedule
Three annual courses of 20 infusions, each with 20 mL Cerebrolysin in 100 mL isotonic saline. Assessments at baseline and months 1, 14, 27 and 30.
Protocol source ↗ · Original indexed Russian and English abstracts, methods and follow-up results.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Conversion to probable Alzheimer’s dementia | None reported in the treated group. The authors give 9.5% annual conversion in the untreated group. | Follow-up to month 30 |
| Clinician-rated improvement after third course | 95.7% pronounced or moderate improvement in the treated group | The abstract reports CGI-I results for this group. |
Source for these results ↗ · Reviewed 2026-11-15
Study limitations and source details
Study limitations
- The comparison group was untreated. The abstract leaves allocation and masking unclear. Annual incidence cannot be converted into a 30-month event count from this percentage alone.
- Earlier reports from the same investigators enrolled first-degree relatives. Participant overlap remains unverified.
Related publications may describe some of the same participants or experiments.
Source details
Original indexed Russian and English abstracts, methods and follow-up results.
Sources checked
Citation
N. D. Selezneva, S. I. Gavrilova. Cerebrolysin in relatives of people with Alzheimer’s disease: 30-month comparison Korsakov Journal of Neurology and Psychiatry. 2023;123(8):90–97.
Study source ↗ · DOI 10.17116/jnevro202312308190 · Bibliography entry · Link to this summary